figshare
Browse
ionc_a_1406141_sm3471.pdf (86.86 kB)

Quality of life and care needs in women with estrogen positive metastatic breast cancer: a qualitative study

Download (86.86 kB)
journal contribution
posted on 2017-12-05, 08:34 authored by Gitte Lee Mortensen, Ivan Bredbjerg Madsen, Randi Krogsgaard, Bent Ejlertsen

Background: In recent years, the prognosis of metastatic breast cancer (MBC) has improved with more effective therapies applicable to a wider range of patients. To many patients, a MBC diagnosis thus initiates a prolonged course of illness and treatment. This qualitative study aimed to explore the long-term health-related quality of life (HRQoL) and support needs in MBC patients of all ages in the Danish context.

Material and methods: Eighteen MBC patients participated in five qualitative focus group interviews that were analyzed using content analysis and a constructivist approach.

Results: The participants described how MBC severely reduced their physical and psychosocial functioning and required a constant adaptation of their quality of life (QoL) standards in relation to their changing life situation and disease progression. Overall, they felt medically well-treated but lacked a multidisciplinary approach to care including psychological support, in particular, but also manual physiotherapy, health care coordination and social counseling. The participants called for continuity of care with the same health care professionals as this facilitated communication and flexibility in planning treatment and controls. They requested a reduction of precious time spend on treatment to enable them to focus on their most meaningful relations and activities.

Conclusion: With the MBC diagnosis, the focus of treatment switches from disease eradication to prolonging survival, alleviating symptoms and improving QoL. To patients, MBC marks a shift in expectations from quantity to quality of life and a perpetual adaptation of their QoL standards. To sustain patients’ HRQoL, it is important that along with improvements in life-prolonging treatment, comprehensive care also supports their main psycho-social needs. These patients needed support in maintaining normality and role functioning enabling them to focus on living, not merely surviving, through this prolonged disease phase.

Funding

The study was funded by an unrestricted research grant from Pfizer, Denmark. Pfizer had no involvement in the methodological design, analysis, manuscript writing or choice of journal.

History